Q4 2024 Management View Chirag Patel, Co-CEO, highlighted Amneal's "stellar financial performance" in 2024, citing double-digit revenue and adjusted EBITDA growth, reduction of net leverage below four ...

Piper Sandler upgraded CAVA Group (NYSE:CAVA) to an Overweight rating on Friday after having the restaurant stock slotted at ...

Piper Sandler analyst Rob Owens raised the firm’s price target on Elastic (ESTC) to $135 from $130 and keeps an Overweight rating on the ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on TransMedics Group (TMDX – Research Report) today and set a price target of ...

Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Kymera Therapeutics (KYMR – Research Report) today and set a price target of ...

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Natera (NTRA – Research Report), with a price target ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR – ...

Piper Sandler lowered the firm’s price target on Bloom Energy (BE) to $31 from $33 and keeps an Overweight rating on the shares. The firm says ...

Piper Sandler analyst Anna Andreeva maintained a Buy rating on On Holding AG (ONON – Research Report) today and set a price target of $62.00.

In a report released today, Brad Capuzzi from Piper Sandler maintained a Hold rating on Rocket Companies (RKT – Research Report), with a price ...

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Amphastar Pharmaceuticals (AMPH – Research Report), ...

Piper Sandler analyst Michael Lavery maintained a Hold rating on Monster Beverage (MNST – Research Report) today and set a price target of ...